Nello Mainolfi sold $2.4M of Kymera Therapeutics (KYMR)

Executed Apr 29, disclosed Apr 29, the same day.

Value, as filed

$2.4M

29,064 sh across 2 lots

Executed

Apr 29

the trade date, as filed

Disclosed

Apr 29

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Nello Mainolfi Chief Executive Officer profile →

Nello Mainolfi (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.2M of KYMR (80,000 sh across 5 lots, as filed), executed Jul 1.

The name

KYMR

Kymera Therapeutics, Inc. KYMR · Healthcare · 59 filings in 24 months ticker →

Healthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Nello Mainolfi in KYMR

KYMRSALE Kymera Therapeutics, Inc. $3.4M
29,738 sh across 5 lots
Exec Oct 1
Filed Oct 1 · 5:20 PM ET KYMRSALE Kymera Therapeutics, Inc. $6.0M
50,000 sh × $119.00
Exec Jul 7
Filed Jul 7 · 8:00 PM ET KYMRSALE Kymera Therapeutics, Inc. $9.2M
80,000 sh across 5 lots
Exec Jul 1
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.7M
29,992 sh across 4 lots
Exec Feb 25
Filed Feb 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.3M
30,000 sh across 2 lots
Exec Dec 31 2025
Filed Dec 31 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $8.9M
100,000 sh × $89.17
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.8M
30,000 sh across 3 lots
Exec Oct 29 2025
Filed Oct 29 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.5M
30,000 sh × $49.00
Exec Sep 16 2025
Filed Sep 16 2025 · 5:30 PM ET